advanced search

CONNECTIVITY

INSULCHECK CONNECT: ADDRESSING ADHERENCE WITH A CLOSED-LOOP SOLUTION
CONNECTIVITY
John Hughes
Innovation Zed
INSULCHECK CONNECT: ADDRESSING ADHERENCE WITH A CLOSED-LOOP SOLUTION
John Hughes and Alina Smotrova discuss the success of the InsulCheck Classic and how user feedback and modern technology has led to the development of its second generation, InsulCheck Connect.
ERIC DESSERTENNE, BIOCORP
INTERVIEW
Eric Dessertenne
Biocorp
ERIC DESSERTENNE, BIOCORP
Eric Dessertenne talks in-depth with ONdrugDelivery Magazine about the ways connectivity is developing within the pharmaceutical industry, its likely future course and how Biocorp is positioned.
EXPANDING CONNECTIVITY: ADD-ONS FOR OPHTHALMIC AND NASAL DELIVERY
CONNECTIVITY
Nemera
EXPANDING CONNECTIVITY: ADD-ONS FOR OPHTHALMIC AND NASAL DELIVERY
Nemera introduces the e-Novelia® and e-Advancia® add-ons for ophthalmic and nasal devices.
LISTEN TO YOUR INHALER, IT MIGHT BE TELLING YOU SOMETHING
EARLY INSIGHT
Dr Kian Min Lim
PA Consulting
LISTEN TO YOUR INHALER, IT MIGHT BE TELLING YOU SOMETHING
Kian Min Lim and David Harris discuss how tailored algorithms can accurately detect inhalers’ acoustic signatures, effectively adding connectivity without having to add a chip to the inhaler.
THE FUTURE OF CONNECTED ASTHMA AND COPD CARE: A STEPWISE DEVELOPMENT
CONNECTIVITY
Dr Benjamin Jung
H&T Presspart
THE FUTURE OF CONNECTED ASTHMA AND COPD CARE: A STEPWISE DEVELOPMENT
Benjamin Jung outlines possible scenarios for the likely steps in the development and adoption of connected devices in the field of asthma and COPD care.
Biocorp’s OneJet<sup>®</sup> connected autoinjector
VIDEO
Biocorp
Biocorp’s OneJet® connected autoinjector
Onejet is the first motor-driven, disposable and connected autoinjector. It's compatible with standard primary containers and is customisable allowing it to easily deliver high viscosity products. Injection data (time, doses and date) are transferred to a mobile app via Bluetooth, allowing monitoring of key treatment information.
THE FUTURE OF DRUG DELIVERY
EXPERT VIEW
Uri Baruch
THE FUTURE OF DRUG DELIVERY
Uri Baruch looks back on how far injectable drug delivery has come in the past thirty years and, with an eye on current trends and the range of innovations in the sector, particularly data and connectivity technology, looks forward to what the future may hold.
CONNECTED, NEEDLE-FREE DRUG DELIVERY
INJECTION
Barbara Taylor
Portal Instruments
CONNECTED, NEEDLE-FREE DRUG DELIVERY
The healthcare industry is seeing an ever growing trend towards patients self-administering their therapies at home. Barbara Taylor discusses this trend and how Portal is making a bold step towards this goal with its novel needle-free injection device.
ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY
WEARABLES
John Love
Enable Injections
ENABLE INJECTIONS AND FLEX SET AMBITIOUS PLANS FOR LARGE VOLUME DRUG DELIVERY
The delivery of high volumes of biologics outside of the clinical setting remains a key challenge in the industry. Here, John Love, Mark Lee and Amy Boyle discuss how the enFuse™ on-body injector, developed by Enable in partnership with Flex, may be the answer.
MEETING FUTURE NEEDS FOR RESPIRATORY DRUG DELIVERY DEVELOPMENT
EXPERT VIEW
Mark Knowles
MEETING FUTURE NEEDS FOR RESPIRATORY DRUG DELIVERY DEVELOPMENT
Mark Knowles and Collette Johnson explore the different elements that need to be considered when developing a smart inhalation drug delivery device to ensure that maximum benefit is obtained.
INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
PREFILLED SYRINGES
SHL Medical
INJECTING HIGH VOLUME, HIGH VISCOSITY DRUGS
SHL details its latest offerings in the world of biologics, as well as its partnership with QuiO, a speciality digital healthcare start-up, to develop injectables in the connected healthcare space.
DIGITISATION & INDUSTRY 4.0 IN PHARMA PRODUCTION
INJECTION
Christoph Hammer
DIGITISATION & INDUSTRY 4.0 IN PHARMA PRODUCTION
Christoph Hammer gives an overview of the Industry 4.0 concept, and its pharmaceutical application Pharma 4.0. Furthermore, Mr Hammer provides examples of what Pharma 4.0 can offer, discussing solutions shown at Interpak 2017, Düsseldorf.
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
PREFILLED SYRINGES
Bill Welch
Phillips-Medisize
CRITICAL CONSIDERATIONS FOR HIGH VISCOSITY/HIGH VOLUME DEVICES
There are some device design considerations that are common across the spectrum of biologics development. Bill Welch discusses these considerations, highlighting the advantage conferred by accounting for them early in the product lifecycle.
CONNECTED HEALTH – AN EFFECTIVE SOLUTION TO IMPROVE ADHERENCE
CONNECTIVITY
Sai Shankar
Aptar Pharma
CONNECTED HEALTH – AN EFFECTIVE SOLUTION TO IMPROVE ADHERENCE
Sai Shankar details the problem of non-adherence, in particular in asthma and COPD, and how its solution, along with myriad other benefits, can be found in digital healthcare and connected devices.
NEIL WILLIAMS, MEDICOM INNOVATION PARTNER
INTERVIEW
Neil Williams
NEIL WILLIAMS, MEDICOM INNOVATION PARTNER
In this interview with ONdrugDelivery Magazine, Williams discusses the crucial role connectivity is taking in the drug delivery device industry.
IMPROVING PATIENTS’ LIVES THROUGH CONNECTIVITY
CONNECTIVITY
Matthieu Hamon
Biocorp
IMPROVING PATIENTS’ LIVES THROUGH CONNECTIVITY
Eric Dessertenne and Matthieu Hamon look at the importance of increasing the connectivity of drug delivery devices to improve patient compliance in the area of chronic disease management. Biocorp aims to use innovations such as Datapen™ and EasyLog™ to help create patient-centric, interconnected care, known as 4P medicine.
SOFTWARE AND SERVICES – THE MISSING LINK FOR CONNECTED THERAPEUTICS
CONNECTIVITY
Alexander Dahmani
SOFTWARE AND SERVICES – THE MISSING LINK FOR CONNECTED THERAPEUTICS
Alexander Dahmani explains how the rise of smart devices and connectivity has enabled QuiO to develop ConnectedRx™, the first cloud platform designed for connected therapeutics, and discusses how ConnectedRx™ programmes can be a step towards solving the ongoing problem of adherence.
HOW CONNECTIVITY WILL REMODEL HEALTHCARE
EXPERT VIEW
Dr Marjorie Villien
HOW CONNECTIVITY WILL REMODEL HEALTHCARE
Marjorie Villien and Jerôme Mouly provide a forecast of the place of connectivity in the healthcare market and the significant changes it is likely to bring to both devices and the market itself.
THE PROMISE OF VOICE: CONNECTING DRUG DELIVERY THROUGH VOICE-ACTIVATED TECHNOLOGY
EXPERT VIEW
Chris Franzese
THE PROMISE OF VOICE: CONNECTING DRUG DELIVERY THROUGH VOICE-ACTIVATED TECHNOLOGY
Chris Franzese and Marty Coyne discuss the vast potential that voice-activated technologies, such as Amazon’s Alexa, have in the healthcare market. Running through the challenges posed by data security and human factors, they go on to explain how the rewards voice-activation offers are well worth the effort, spanning the drug delivery experience.
CONNECTIVITY IN DRUG DELIVERY
CONFERENCE REVIEW
Napoleon Monroe
CONNECTIVITY IN DRUG DELIVERY
Napoleon Monroe summarises the intensifying coverage of connectivity as a key theme at two recent drug delivery conferences he attended, Partnerships in Drug Delivery and PDA’s Universe of Prefilled Syringes and Injection Devices.
ENERGY HARVESTING: POWERING CONNECTED DRUG DELIVERY DEVICES
EXPERT VIEW
Charlotte Harvey
ENERGY HARVESTING: POWERING CONNECTED DRUG DELIVERY DEVICES
Charlotte Harvey examines the opportunities and practicalities of using energy harvesting technologies in drug delivery devices. With a specific focus on enabling connectivity functionality, Ms Harvey runs through the various aspects of energy harvesting and offers insight on whether it is the right choice for a new device development.
PARTNERING FOR BLUETOOTH: THE SMART ROAD TO CONNECTIVITY
CONNECTIVITY
Thomas Soederholm
PARTNERING FOR BLUETOOTH: THE SMART ROAD TO CONNECTIVITY
Thomas Soederholm explains how advances in wireless technology, such as new Bluetooth Low Energy chips and design tools, are now being used in wireless medical product development and how incorporating them can be made much easier by partnering with a specialist vendor.
DATA IS DRIVING THE FUTURE OF NEUROTECHNOLOGY WITH CRANIALCLOUD
CONNECTIVITY
Will Rosellini
DATA IS DRIVING THE FUTURE OF NEUROTECHNOLOGY WITH CRANIALCLOUD
Will Rosellini, Nexeon Medsystems, and Pierre-Francois D’Haese, Neurotargeting, discuss the neurotechnology market and how the Internet of Medical Things is creating exciting opportunities in the space. looking specifically at the collaboration centring Nexeon’s Deep Brain Stiumulation technology and Neurotargeting’s CrainialCloud.
A REVIEW OF REUSABLE AUTO-INJECTORS FOR BIOLOGICAL & BIOSIMILAR DRUGS
PREFILLED SYRINGES
Dr Menachem Zucker
A REVIEW OF REUSABLE AUTO-INJECTORS FOR BIOLOGICAL & BIOSIMILAR DRUGS
From the perspective of the growing biologics and emerging biosimilars markets, Menachem Zucker showcases E3D – Elcam Drug Delivery Devices' mechanical and electronic auto-injector platforms, both of which are reusable devices with disposable cassettes.
Top